RPT Lab works

RPT Labworks, Inc. is a Madison-based radiopharmaceutical Contract Research Organization (CRO) dedicated to accelerating the translational path to the clinic. Operating a state-of-the-art 6,000-sq-ft facility, we serve as an agile extension of the scientific R&D team for global pharma, biotechs, and academic innovators, eliminating typical bottlenecks and delays inherent in early translational pipelines. Driven by a leadership team with combined over 50 years of cross-disciplinary expertise in nuclear medicine, molecular imaging, medical physics, and cancer biology, RPT Labworks masters complex study designs and delivers action-oriented data within a 2-to-4-week turnaround window. End-to-End Preclinical Capabilities: Strategic Consulting & Study Design: Discovery through clinical translation; Custom Radiochemistry: Vector- and radionuclideagnostic labeling, purification, and QC; In Vitro & Cancer Modeling: Cellular assays and advanced in vivo models (CDX, PDX); Advanced In Vivo Imaging: Quantitative micro-PET/CT and SPECT/CT biodistribution; Efficacy & RadTox: Longitudinal therapeutic response monitoring, survival outcomes, and targeted radiation toxicity profiling; Ex Vivo Analytics: 20-organ/tissue harvesting (“cut and count”), autoradiography, and toxicity; IND-Ready Dosimetry: Image- and model-based human dose projections; No matter the vector driving your RPT pipeline, RPT Labworks delivers the rigorous, reproducible science needed to advance your therapeutic asset with absolute confidence.

www.rptlabworks.com